Cita APA

Taylor, B., Sun, X., Gonzalez-Ericsson, P., Sanchez, V., Sanders, M., Wescott, E., . . . Balko, J. (2024). NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.

Citación estilo Chicago

Taylor, BC, et al. NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer. 2024.

Cita MLA

Taylor, BC, et al. NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer. 2024.